Effectiveness of the association of 2 probiotic strains formulated in a slow release vaginal product, in women affected by vulvovaginal candidiasis: A pilot study

Journal of Clinical Gastroenterology

Volumn 46, Issue SUPPL. 1, 2012, Pages

  Vicariotto, Franco ^a   Del Piano, Mario ^b   Mogna, Luca ^c   Mogna, Giovanni ^d  

^a Gynaecology Unit   (Italy)

^b MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

^c Biolab Research Srl   (Italy)

^d Probiotical SpA   (Italy)

Author keywords

barrier effect; probiotic strain; vaginal microbiota; vulvovaginal candidiasis (VVC)

Indexed keywords

PROBIOTIC AGENT;

ADULT; ARTICLE; BACTERIAL COLONIZATION; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFICACY; DRUG FORMULATION; FEMALE; GROWTH INHIBITION; HUMAN; IN VITRO STUDY; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS FERMENTUM; PILOT STUDY; PRIORITY JOURNAL; RELAPSE; TREATMENT DURATION; VAGINA CANDIDIASIS;

ADULT; ANTIBIOSIS; CANDIDA; CANDIDA ALBICANS; CANDIDIASIS, VULVOVAGINAL; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS FERMENTUM; MIDDLE AGED; PILOT PROJECTS; PROBIOTICS; TABLETS; TREATMENT OUTCOME; VAGINA; YOUNG ADULT;

EID: 84866237256     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3182684d71     Document Type: Article

References (37)

1. Marelli G, Papaleo E, Ferrari A. Lactobacilli for prevention of urogenital infections: a review. Eur Rev Med Pharmacol Sci. 2004;8:87-95. (Pubitemid 38961748)
2. Verstraelen H. Cutting edge: the vaginal microflora and bacterial vaginosis. Verh K Acad Geneeskd Belg. 2008;70:147-174.
3. Kim J, Sudbery P. Candida albicans, a major human fungal pathogen. J Microbiol. 2011;49:171-177.
4. Achkar JM, Fries BC. Candida infections of the genitourinary tract. Clin Microbiol Rev. 2010;23:253-273.
5. Mahmoudi Rad M, Zafarghandi S, Abbasabadi B, et al. The epidemiology of Candida species associated with vulvovaginal candidiasis in an Iranian patient population. Eur J Obstet Gynecol Reprod Biol. 2011;155:199-203.
6. Cetin M, Ocak S, Gungoren A, et al. Distribution of Candida species in women with vulvovaginal symptoms and their association with different ages and contraceptive methods. Scand J Infect Dis. 2007;39:584-588. (Pubitemid 47009169)
7. Sobel JD, Faro S, Force RW, et al. Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. Am J Obstet Gynecol. 1998;178:203-211. (Pubitemid 28124116)
8. Sobel JD. Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis. Am J Obstet Gynecol. 1985;152:924-935. (Pubitemid 15016406)
9. Sobel JD, Wiesenfeld HC, Martens M, et al. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis. N Engl J Med. 2004;351:876-883.
10. Babic M, Hukic M. Candida albicans and non-albicans species as etiological agent of vaginitis in pregnant and nonpregnant women. Bosn J Basic Med Sci. 2010;10:89-97.
11. Fidel PL Jr, Sobel JD. Immunopathogenesis of recurrent vulvovaginal candidiasis. Clin Microbiol Rev. 1996;9:335-348. (Pubitemid 26245614)
12. Anderson MR, Klink K, Cohrssen A. Evaluation of vaginal complaints. JAMA. 2004;291:1368-1379. (Pubitemid 38541652)
13. Pappas PG, Kauffman CA, Andes D, et al. Infectious Diseases Society of America. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;48:503-535.
14. Hill DR, Brunner ME, Schmitz DC, et al. In vivo assessment of human vaginal oxygen and carbon dioxide levels during and post menses. J Appl Physiol. 2005;99:1582-1591. (Pubitemid 43014370)
15. Wira CR, Fahey JV, Ghosh M, et al. Sex hormone regulation of innate immunity in the female reproductive tract: the role of epithelial cells in balancing reproductive potential with protection against sexually transmitted pathogens. Am J Reprod Immunol. 2010;63:544-565.
16. Nansel TR, Riggs MA, Yu KF, et al. The association of psychosocial stress and bacterial vaginosis in a longitudinal cohort. Am J Obstet Gynecol. 2006;194:381-386. (Pubitemid 43183688)
17. Geiger AM, Foxman B. Risk factors for vulvovaginal candidiasis: a case-control study among university students. Epidemiology. 1996;7:182-187. (Pubitemid 26068052)
18. Kent HL. Epidemiology of vaginitis. Am J Obstet Gynecol. 1991;165:1168-1176.
19. Parveen N, Munir AA, Din I, et al. Frequency of vaginal candidiasis in pregnant women attending routine antenatal clinic. J Coll Physicians Surg Pak. 2008;18:154-157. (Pubitemid 351676188)
20. Quan M. Vaginitis: diagnosis and management. Postgrad Med. 2010;122:117-127.
21. Sobel JD. Recurrent vulvovaginal candidiasis: a prospective study of the efficacy of maintenance ketoconazole therapy. N Engl J Med. 1986;4:1455-1458. (Pubitemid 17051706)
22. Merkus JM, Van Heusden AM. Chronic vulvovaginal candidosis: the role of oral treatment. Br J Clin Pract Suppl. 1990;71:81-84.
23. Lewis JH, Zimmerman HJ, Benson GD, et al. Hepatic injury associated with ketoconazole therapy: analysis of 33 cases. Gastroenterology. 1984;86:503-513. (Pubitemid 14154661)
24. Dö derlein A. Vaginal Secretions and their Impotance in the Postpartum Period. Leipzig. 1892.
25. Falagas ME, Betsi GI, Athanasiou S. Probiotics for prevention of recurrent vulvovaginal candidiasis: a review. J Antimicrob Chemother. 2006;58:266-272. (Pubitemid 44294935)
26. Nishijima K, Shukunami K, Kotsuji F. Probiotics affects vaginal flora in pregnant women, suggesting the possibility of preventing preterm labor. J Clin Gastroenterol. 2005;39: 447-448. (Pubitemid 40548086)
27. Rö nnqvist PD, Forsgren-Brusk UB, Grahn-Ha? kansson EE. Lactobacilli in the female genital tract in relation to other genital microbes and vaginal pH. Acta Obstet Gynecol Scand. 2006;85:726-735.
28. Strus M, Kucharska A, Kukla G, et al. The in vitro activity of vaginal Lactobacillus with probiotic properties against Candida. Infect Dis Obstet Gynecol. 2005;13:69-75. (Pubitemid 40979012)
29. Mastromarino P, Brigidi P, Macchia S, et al. Characterization and selection of vaginal Lactobacillus strains for the preparation of vaginal tablets. J Appl Microbiol. 2002;93:884-893. (Pubitemid 35340893)
30. Byun R, Nadkarni MA, Chhour KL, et al. Quantitative analysis of diverse Lactobacillus species present in advanced dental caries. J Clin Microbiol. 2004;42:3128-3136. (Pubitemid 38938069)
31. Walter J, Tannock GW, Tilsala T, et al. Detection and identification of gastrointestinal Lactobacillus species by using denaturing gradient gel electrophoresis and species-specific PCR primers. Appl Environ Microbiol. 2000;66:297-303. (Pubitemid 30030531)
32. Tynkkynen S, Satokari R, Saarela M, et al. Comparison of ribotyping, randomly amplified polymorphic DNA analysis, and pulsed-field gel electrophoresis in typing of Lactobacillus rhamnosus and L. casei strains. Appl Environ Microbiol. 1999; 65:3908-3914.
33. Sobel JD, Kapernick PS, Zervos M, et al. Treatment of complicated Candida vaginitis: comparison of single and sequential doses of fluconazole. Am J Obstet Gynecol. 2001; 185:363-369. (Pubitemid 32769437)
34. Walker GM. Yeast Physiology and Biotechnology. Baffins Lane, Chichester, UK: John Wiley & Sons Ltd; 1998.
35. Espinel-Ingroff A, Stockman L, Roberts G, et al. Comparison of RapID yeast plus system with API 20C system for identification of common, new, and emerging yeast pathogens. J Clin Microbiol. 1998;36:883-886. (Pubitemid 28146263)
36. Lepargneur JP, Rousseau V. Protective role of the Doderle?̈n flora. J Gynecol Obstet Biol Reprod (Paris). 2002; 31:485-494.
37. Gillor O, Etzion A, Riley MA. The dual role of bacteriocins as anti-and probiotics. Appl Microbiol Biotechnol. 2008;81: 591-606.